No significant difference up to six months after the diagnosis date was found in the prescription of cholinesterase inhibitors, memantine and antipsychotics, except for higher use of memantine at three and six months after dementia diagnosis in the post-COVID-19 period. This evidence concerns the gene BCHE and dementia.